Tojo Akihiro, Kinugasa Satoshi, Fujita Toshiro, Wilcox Christopher S
Division of Nephrology and Endocrinology, The University of Tokyo, Tokyo, Japan.
Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan.
Diabetes Metab Syndr Obes. 2016 Jan 18;9:1-10. doi: 10.2147/DMSO.S91245. eCollection 2016.
The mechanism of activation of local renal renin-angiotensin system (RAS) has not been clarified in diabetes mellitus (DM). We hypothesized that the local renal RAS will be activated via increased glomerular filtration and tubular uptake of prorenin and angiotensinogen in diabetic kidney with microalbuminuria. Streptozotocin (STZ)-induced DM and control rats were injected with human prorenin and subsequently with human angiotensinogen. Human prorenin uptake was increased in podocytes, proximal tubules, macula densa, and cortical collecting ducts of DM rats where prorenin receptor (PRR) was expressed. Co-immunoprecipitation of kidney homogenates in DM rats revealed binding of human prorenin to the PRR and to megalin. The renal uptake of human angiotensinogen was increased in DM rats at the same nephron sites as prorenin. Angiotensin-converting enzyme was increased in podocytes, but decreased in the proximal tubules in DM rats, which may have contributed to unchanged renal levels of angiotensin despite increased angiotensinogen. The systolic blood pressure increased more after the injection of 20 μg of angiotensinogen in DM rats than in controls, accompanied by an increased uptake of human angiotensinogen in the vascular endothelium. In conclusion, endocytic uptake of prorenin and angiotensinogen in the kidney and vasculature in DM rats was contributed to increased tissue RAS and their pressor response to angiotensinogen.
糖尿病(DM)中局部肾素 - 血管紧张素系统(RAS)的激活机制尚未阐明。我们推测,在伴有微量白蛋白尿的糖尿病肾脏中,局部肾RAS将通过肾小球滤过增加以及肾素原和血管紧张素原的肾小管摄取增加而被激活。用链脲佐菌素(STZ)诱导糖尿病大鼠和对照大鼠,随后分别注射人肾素原和人血管紧张素原。在表达肾素原受体(PRR)的糖尿病大鼠的足细胞、近端小管、致密斑和皮质集合管中,人肾素原摄取增加。糖尿病大鼠肾脏匀浆的免疫共沉淀显示人肾素原与PRR和巨膜蛋白结合。糖尿病大鼠中,人血管紧张素原在与肾素相同的肾单位部位摄取增加。糖尿病大鼠足细胞中的血管紧张素转换酶增加,但近端小管中减少,这可能是尽管血管紧张素原增加但肾脏中血管紧张素水平未改变的原因。糖尿病大鼠注射20μg血管紧张素原后收缩压升高幅度大于对照大鼠,同时血管内皮中人血管紧张素原摄取增加。总之,糖尿病大鼠肾脏和血管中肾素原和血管紧张素原的内吞摄取导致组织RAS增加及其对血管紧张素原的升压反应。